Shirish Gundopant Belapure

Shirish Gundopant Belapure

Active Director Director DIN 02219458
DIN 02219458 First appointment Jul 2008 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 9 active board seats
Past companies 3 historical roles
Total affiliations 12 Since Jul 2008
Shareholding value •••• Premium profile

About Shirish Gundopant Belapure

Data last updated:

Shirish Gundopant Belapure is a Director at Jubilant Pharmova Limited (since 2023), Director at Innova Captab Limited (since 2022) and Director at Corona Remedies Limited (since 2025), and holds 6 more current directorships. The companies operate in Pharma and Chemicals. The 8 current companies with reported revenue have a combined latest revenue of ₹12,439 Cr; the largest is Jubilant Pharmova Limited at ₹8,346 Cr (FY 2026). Earlier, Shirish Gundopant Belapure was a Director at Albert David Ltd (2019–2025) and Director at Windlas Healthcare Private Limited (2019–2020) and 1 more.

DIN 02219458
Primary Designation Director
Industry Pharma
First Appointment 16 Jul 2008
Oldest Company Age 48 yrs
Largest company Jubilant Pharmova Limited · ₹8,346 Cr (FY 2026)
Combined revenue ₹12,439 Cr across 8 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Jubilant Pharmova Limited L24116UP1978PLC004624
Director07 Mar 20231978₹8,346 Cr (FY 2026)Active
Innova Captab Limited L24246MH2005PLC150371
Director01 Apr 20222005₹1,637 Cr (FY 2026)Active
Corona Remedies Limited L24231GJ2004PLC044656
Director04 Jan 20252004₹1,202 Cr (FY 2025)Active
New Life Medicals Private Limited U51909GJ2020PTC114565
Additional Director29 Dec 20252020₹622 Cr (FY 2025)Active
Jubilant Generics Limited U24100UP2013FLC060821
Director20 Jun 20242013₹327 Cr (FY 2023)Active
Natural Capsules Limited L85110KA1993PLC014742
Director10 Aug 20221993₹170 Cr (FY 2025)Active
Partner01 Jul 20202020₹79.26 Cr (FY 2023)Active
Uniza Lifecare Private Limited U24230GJ2020PTC113820
Director22 Oct 20202020₹55.25 Cr (FY 2025)Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Albert David Ltd L51109WB1938PLC009490
Director14 Feb 20191938₹420 Cr (FY 2024)Active
Windlas Healthcare Private Limited U85100UR2010PTC033065
Director18 Mar 20192010₹24.17 Cr (FY 2020)Amalgamated
Managing Director16 Jul 20082005₹431 Cr (FY 2025)Active

Explore Director's current and past company associations Uncover their professional journey today!

Board colleagues of Shirish Gundopant Belapure

Directorship timeline

Open interactive timeline →
Bellapure Onco Phytoceuticals Llp
Uniza Healthcare Llp
Natural Capsules Limited
Uniza Lifecare Private Limited
Premium access

Shareholding and investment profile for Shirish Gundopant Belapure

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Shirish Gundopant Belapure

Shirish Gundopant Belapure currently holds 9 directorships: Jubilant Pharmova Limited (Director, since 07 Mar 2023, revenue ₹8,346 Cr (FY 2026)); Innova Captab Limited (Director, since 01 Apr 2022, revenue ₹1,637 Cr (FY 2026)); Corona Remedies Limited (Director, since 04 Jan 2025, revenue ₹1,202 Cr (FY 2025)); New Life Medicals Private Limited (Additional Director, since 29 Dec 2025, revenue ₹622 Cr (FY 2025)); Jubilant Generics Limited (Director, since 20 Jun 2024, revenue ₹327 Cr (FY 2023)); and 4 more.

Shirish Gundopant Belapure was first appointed on 16 Jul 2008 as Managing Director at Zydus Hospira Oncology Private Limited. The most recent appointment on record is 29 Dec 2025 at New Life Medicals Private Limited.

The 8 current companies of Shirish Gundopant Belapure that report revenue have a combined latest revenue of ₹12,439 Cr: Jubilant Pharmova Limited ₹8,346 Cr (FY 2026); Innova Captab Limited ₹1,637 Cr (FY 2026); Corona Remedies Limited ₹1,202 Cr (FY 2025); New Life Medicals Private Limited ₹622 Cr (FY 2025); Jubilant Generics Limited ₹327 Cr (FY 2023); and 3 more.

Shirish Gundopant Belapure held 3 earlier board appointments: Albert David Ltd (Director, 14 Feb 2019 to 10 Mar 2025); Windlas Healthcare Private Limited (Director, 18 Mar 2019 to 30 Apr 2020); Zydus Hospira Oncology Private Limited (Managing Director, 16 Jul 2008 to 31 Dec 2018).

The current boards of Shirish Gundopant Belapure's companies include Arjun Shanker Bhartia (Jubilant Pharmova Limited), Arun Seth (Jubilant Pharmova Limited), Ashish Omprakash Mukkirwar (Jubilant Pharmova Limited), Hari Shanker Bhartia (Jubilant Pharmova Limited), Harsh Mahajan (Jubilant Pharmova Limited), Naresh Kapoor (Jubilant Pharmova Limited), among others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available